Page last updated: 2024-10-18

dihydroxyphenylalanine and Hallervorden-Spatz Disease

dihydroxyphenylalanine has been researched along with Hallervorden-Spatz Disease in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saïd, G1
Tkachev, RA1
Markova, ED1
Gotovtseva, EV1
Barkhatova, VP1
Ivanova-Smolenskaia, IA1

Other Studies

2 other studies available for dihydroxyphenylalanine and Hallervorden-Spatz Disease

ArticleYear
[Dystonias].
    La Nouvelle presse medicale, 1972, Feb-19, Volume: 1, Issue:8

    Topics: 5-Hydroxytryptophan; Adolescent; Adult; Dihydroxyphenylalanine; Dystonia Musculorum Deformans; Extra

1972
[Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1973, Volume: 73, Issue:4

    Topics: Adolescent; Adult; Atropine; Basal Ganglia Diseases; Chelating Agents; Chronic Disease; Dihydroxyphe

1973
chemdatabank.com